> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-203/
- Published: 2018-11-11T12:00:00.000Z
- Updated: 2026-09-15T00:43:48.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142794

[**Axiron Not Withdrawn Over Safety/Efficacy**](https://www.fdaweb.com/axiron-not-withdrawn-over-safety-efficacy/)  
*Federal Register* notice: FDA determines that Eli Lilly’s Axiron (testosterone) transdermal metered solution, 30 mg/1.5 ml actuation was not withdrawn for safety or effectiveness reasons. 11/08/2018

[**Pilot Survey to Assess Allergy to Cosmetics**](https://www.fdaweb.com/pilot-survey-to-assess-allergy-to-cosmetics/)  
*Federal Register* notice: FDA seeks comments on a new proposed information collection entitled “Web-Based Pilot Survey To Assess Allergy to Cosmetics in the U.S.” 11/08/2018

[**Draft Guide on Drug Safety Meta-Analyses**](https://www.fdaweb.com/draft-guide-on-drug-safety-meta-analyses/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Meta-Analyses of Randomized Controlled Clinical Trials to Evaluate the Safety of Human Drugs or Biological Products.” 11/07/2018

[**Info Collection on Postmarket Drug Reporting**](https://www.fdaweb.com/info-collection-on-postmarket-drug-reporting/)  
*Federal Register* notice: FDA submits to OMB a revised information collection on “Postmarketing Adverse Drug and Biological Product Experience Reporting and Recordkeeping.” 11/07/2018

[**Guide on Developing Fixed-Combination Hypertension Drugs**](https://www.fdaweb.com/guide-on-developing-fixed-combination-hypertension-drugs/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Hypertension: Developing Fixed- Combination Drug Products for Treatment.” 11/07/2018

[**Info Collection Revision on Tropical Disease Vouchers**](https://www.fdaweb.com/info-collection-revision-on-tropical-disease-vouchers/)  
*Federal Register* notice: FDA seeks comments on an information collection revision for “Tropical Disease Priority Review Vouchers.” 11/06/2018

[**Info Collection Extension on Expanded Access Guide**](https://www.fdaweb.com/info-collection-extension-on-expanded-access-guide/)  
*Federal Register* notice. FDA seeks comments on an information collection extension for its “Guidance for Industry on Individual Patient Expanded Access Applications: Form FDA 3926” (OMB Control Number 0910-0814). 11/06/2018

[**FDA Guide on Device UDI Compliance Dates**](https://www.fdaweb.com/fda-guide-on-device-udi-compliance-dates/)  
*Federal Register* notice: FDA makes available a guidance entitled “Unique Device Identification: Policy Regarding Compliance Dates for Class I and Unclassified Devices and Certain Devices Requiring Direct Marking.” 11/05/2018

[**Info Collection Extension for Biosimilar User Fees**](https://www.fdaweb.com/info-collection-extension-for-biosimilar-user-fees/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for “Biosimilars User Fee Program.” 11/05/2018